LON:HVO hVIVO (HVO) Share Forecast, Price & News GBX 20 +0.05 (+0.25%) (As of 03:41 PM ET) Add Compare Share Share Today's Range 19.77▼ 20.1850-Day Range 16.75▼ 20.1052-Week Range 9.20▼ 23.40Volume5.05 million shsAverage Volume2.00 million shsMarket Capitalization£136.07 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsDividendHeadlinesProfileChartCompetitorsDividendHeadlines About hVIVO (LON:HVO) StockhVIVO plc (ticker: HVO) (formerly Open Orphan plc) is a rapidly growing specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease vaccines and therapeutics using human challenge clinical trials. The Group provides end-to-end early clinical development services to its large, established and growing repeat client base, which includes four of the top 10 largest global biopharma companies. The Group's fast-growing services business includes a unique portfolio of 10+ human challenge models to test a broad range of infectious and respiratory disease products, world class challenge agent manufacturing, specialist drug development and clinical consultancy services via its Venn Life Sciences brand, and a lab offering via its hLAB brand, which includes virology, immunology biomarker and molecular testing. The Group offers additional clinical field trial services such as patient recruitment and clinical trial site services. hVIVO runs challenge studies in London from its Whitechapel quarantine clinic, its state-of-the-art QMB clinic with its highly specialised on-site virology and immunology laboratory, and its clinic in Plumbers Row. To recruit volunteers / patients for its studies, the Company leverages its unique clinical trial recruitment capacity via its FluCamp volunteer screening facilities in London and Manchester.Read More HVO Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HVO Stock News HeadlinesSeptember 21, 2023 | finance.yahoo.comWhat Is hVIVO plc's (LON:HVO) Share Price Doing?September 12, 2023 | finance.yahoo.comhVIVO has "the perfect opportunity" after strong first halfOctober 4, 2023 | Edge On The Street (Ad)The Strategic Gold Play You Haven't Heard AboutExperts recommend adding gold to your portfolio, but in what form? Some savvy investors are now rejecting coins and mining stocks in favor of a unique gold investment alternative. It holds explosive growth potential similar to a junior gold stock -- but with less risk exposure. September 12, 2023 | msn.comhVIVO raises 2023 revenue view on demand for respiratory therapy testingsJuly 29, 2023 | uk.movies.yahoo.comThis ex-penny stock just paid its first ever dividend. Here’s how muchJuly 25, 2023 | finance.yahoo.comhVIVO signs second bespoke human challenge model contract in as many monthsJuly 19, 2023 | uk.finance.yahoo.comHVO.L - hVIVO plcJuly 13, 2023 | finance.yahoo.comLoss-Making hVIVO plc (LON:HVO) Set To BreakevenOctober 4, 2023 | Edge On The Street (Ad)The Strategic Gold Play You Haven't Heard AboutExperts recommend adding gold to your portfolio, but in what form? Some savvy investors are now rejecting coins and mining stocks in favor of a unique gold investment alternative. It holds explosive growth potential similar to a junior gold stock -- but with less risk exposure. June 28, 2023 | finance.yahoo.comhVIVO to develop first commercial hMPV human challenge modelJune 2, 2023 | finance.yahoo.comhVIVO plc's (LON:HVO) Shares Not Telling The Full StoryMay 16, 2023 | finance.yahoo.comOne hVIVO Insider Raised Their Stake In The Previous YearMay 16, 2023 | finance.yahoo.comOne hVIVO Insider Raised Their Stake In The Previous Year \April 30, 2023 | finance.yahoo.comDespite shrinking by UK£15m in the past week, hVIVO (LON:HVO) shareholders are still up 100% over 3 yearsApril 25, 2023 | finance.yahoo.comhVIVO reveals audited results for "transformational" 2022March 9, 2023 | finance.yahoo.comhVIVO plc (HVO.L)March 8, 2023 | finance.yahoo.comIs hVIVO plc (LON:HVO) Worth UK£0.2 Based On Its Intrinsic Value?February 12, 2023 | msn.comThis ex-penny stock is up 111% in 6 weeks. Should I buy more?February 4, 2023 | msn.com3 no-brainer UK shares to buy in FebruaryFebruary 3, 2023 | finance.yahoo.comWe Might See A Profit From hVIVO plc (LON:HVO) SoonJanuary 26, 2023 | lse.co.ukHvivo Plc Share Price (HVO.GB.PL)January 10, 2023 | finance.yahoo.comFollowing a 34% decline over last year, recent gains may please hVIVO plc (LON:HVO) institutional ownersJanuary 7, 2023 | fool.co.uk1 penny stock I’m buying right now!December 8, 2022 | finance.yahoo.comIs hVIVO plc (LON:HVO) Potentially Undervalued?December 7, 2022 | uk.finance.yahoo.com1 penny stock under 13p I’d snap up right nowNovember 17, 2022 | finance.yahoo.comInvestors in hVIVO (LON:HVO) have unfortunately lost 52% over the last yearOctober 26, 2022 | proactiveinvestors.comhVIVO is a world leader in testing infectious and respiratory disease products using human challenge clinical trialsSee More Headlines Receive HVO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for hVIVO and its competitors with MarketBeat's FREE daily newsletter. Email Address HVO Company Calendar Last Earnings4/19/2018Today10/04/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolLON:HVO Previous SymbolLON:RVG CUSIPN/A CIKN/A Webhvivo.com Phone+44-20-77561300FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E Ratio16.67 P/E GrowthN/ANet Income£-1,060,000.00 Net Margins-1.53% Pretax MarginN/A Return on Equity-3.80% Return on Assets8.20% Debt Debt-to-Equity Ratio7.73 Current Ratio1.42 Quick Ratio1.16 Sales & Book Value Annual Sales£50.70 million Price / Sales2.68 Cash FlowGBX 4.05 per share Price / Cash Flow4.94 Book ValueGBX 3 per share Price / Book6.67Miscellaneous Outstanding Shares680,370,000Free FloatN/AMarket Cap£136.07 million OptionableNot Optionable Beta1.04 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesDr. Yamin Mohammed Khan Ph.D. (Age 54)CEO & Director Mr. Stephen PinkertonCFO & Exec. DirectorMr. Andrew CatchpoleChief Scientific OfficerDr. Maurice N. Treacy Ph.D.Chief Commercial OfficerMs. Teja Marathe-SarvadikarHead of QAKey CompetitorsScancellLON:SCLPCircassia GroupLON:CIRFutura MedicalLON:FUMArix BioscienceLON:ARIXTiziana Life SciencesLON:TILSView All Competitors HVO Stock - Frequently Asked Questions How have HVO shares performed in 2023? hVIVO's stock was trading at GBX 10 at the start of the year. Since then, HVO stock has increased by 100.0% and is now trading at GBX 20. View the best growth stocks for 2023 here. How were hVIVO's earnings last quarter? hVIVO plc (LON:HVO) released its quarterly earnings data on Thursday, April, 19th. The company reported ($16.50) earnings per share for the quarter, missing analysts' consensus estimates of ($10.90) by $5.60. hVIVO had a negative trailing twelve-month return on equity of 3.80% and a negative net margin of 1.53%. How often does hVIVO pay dividends? What is the dividend yield for hVIVO? hVIVO declared a dividend on Tuesday, April 25th. Investors of record on Thursday, May 4th will be paid a dividend of GBX 0.45 per share on Friday, June 9th. This represents a dividend yield of 2.65%. The ex-dividend date of this dividend is Thursday, May 4th. The official announcement can be accessed at this link. Read our dividend analysis for HVO. What other stocks do shareholders of hVIVO own? Based on aggregate information from My MarketBeat watchlists, some companies that other hVIVO investors own include ValiRx (VAL), boohoo group (BOO), Petrofac (PFC), Falanx Group (FLX), IQE (IQE), Scirocco Energy Plc (SOLO.L) (SOLO), CyanConnode (CYAN), Eckoh (ECK), Enanta Pharmaceuticals (ENTA) and Lloyds Banking Group (LLOY). What is hVIVO's stock symbol? hVIVO trades on the London Stock Exchange (LON) under the ticker symbol "HVO." How do I buy shares of hVIVO? Shares of HVO stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What is hVIVO's stock price today? One share of HVO stock can currently be purchased for approximately GBX 20. How much money does hVIVO make? hVIVO (LON:HVO) has a market capitalization of £136.07 million and generates £50.70 million in revenue each year. How can I contact hVIVO? hVIVO's mailing address is Q M B Innovation Centre, 42 New Road, LONDON, E1 2AX, United Kingdom. The official website for the company is hvivo.com. The company can be reached via phone at +44-20-77561300. This page (LON:HVO) was last updated on 10/4/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding hVIVO plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.